Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
Abstract Cyclin D1, a G1-S phase regulator, is upregulated in parathyroid adenomas. Since cyclin-dependent kinase (CDK) inhibitors, CDKN2A and CDKN2B, and RASSF1A (Ras-association domain family 1, isoform A) are involved in G1-S phase arrest and act as potential tumor suppressor genes, we aimed to s...
Guardado en:
Autores principales: | Ashutosh Kumar Arya, Sanjay Kumar Bhadada, Priyanka Singh, Naresh Sachdeva, Uma Nahar Saikia, Divya Dahiya, Arunanshu Behera, Anil Bhansali, Sudhaker D. Rao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a07776f1a83430da8cbd57ec4cd330f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of CDKN2A/CDKN2B Gene Polymorphisms with Increased Susceptibility to Intracranial Aneurysm in a Chinese Han Population
por: Cui X, et al.
Publicado: (2021) -
Miz1 is a critical repressor of cdkn1a during skin tumorigenesis.
por: Jan Hönnemann, et al.
Publicado: (2012) -
The key to simplified management of an undescended parathyroid adenoma
por: Humberto Ruiz-Hernández, et al.
Publicado: (2021) -
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer
por: Stanley I. Gutiontov, et al.
Publicado: (2021) -
A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis
por: Paul Krimpenfort, et al.
Publicado: (2019)